Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: March 30, 2020

DrugPatentWatch Database Preview

Drug Price Trends for LETROZOLE


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for LETROZOLE

Average Pharmacy Cost for LETROZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LETROZOLE 2.5 MG TABLET 50268-0476-15 0.14202 EACH 2020-03-18
LETROZOLE 2.5 MG TABLET 69117-0004-01 0.14202 EACH 2020-03-18
LETROZOLE 2.5 MG TABLET 16729-0034-10 0.14202 EACH 2020-03-18
LETROZOLE 2.5 MG TABLET 00093-7620-56 0.14202 EACH 2020-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LETROZOLE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FEMARA TABLETS Novartis Pharmaceuticals Corporation 00078-0249-15 30 522.21 17.40700 EACH 2019-01-01 - 2020-03-31 Big4
FEMARA TABLETS Novartis Pharmaceuticals Corporation 00078-0249-15 30 690.79 23.02633 EACH 2019-01-01 - 2020-03-31 FSS
FEMARA TABLETS Novartis Pharmaceuticals Corporation 00078-0249-15 30 520.10 17.33667 EACH 2020-01-01 - 2020-03-31 Big4
FEMARA TABLETS Novartis Pharmaceuticals Corporation 00078-0249-15 30 690.79 23.02633 EACH 2020-01-01 - 2020-03-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
Johnson and Johnson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.